Absci
1 known investors
Absci uses AI and wet lab research in iterative cycles to design novel antibody therapeutics and biologics for drug discovery. The company develops candidates for diseases including androgenetic alopecia through integrated computational design and laboratory validation.
AI & Machine LearningBiotechDeep Tech
Investors · 1
In the news
- H.C. Wainwright raises Absci stock price target on trial data By Investing.cominvesting.com · 2026
- Absci (ABSI) Surges 20% in Premarket Following $100M Financing Dealgurufocus.com · 2026
- Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program - Absci (NASD - Benzingabenzinga.com · 2026
- Absci Raises $100 Million in Underwritten Offering to Advance ABS-201 Across Androgenetic Alopecia and Endometriosis | Quiver Quantitativequiverquant.com · 2026
- Absci (NASDAQ: ABSI) prices $100M underwritten equity deal to fund ABS-201stocktitan.net · 2026
- Absci raises $100M as Lilly joins investors backing AI drug programstocktitan.net · 2026